Author

Bob Argiropoulos

Alberta Children’s Hospital Research Institute - Cited by 3,441

Biography

Bob Argiropoulos is a Professor at the Pathology and Cytopathology department, Alberta Children’s Hospital Research Institute, University of Calgary, Hospital Drive NW, Calgary, AB, Canada. He has published over 50 refereed articles in a wide range of highly recognised international journals. He has a keen interest in Prenatal Diagnosis. He is currently working in the project ‘’ MEIS1 regulation’’. His research focuses on Human Molecular Genetics.
Title
Cited by
Year
Disruption of the ASTN2/TRIM32 locus at 9q33.1 is a risk factor in males for autism spectrum disorders, ADHD and other neurodevelopmental phenotypes
AC Lionel, K Tammimies, AK Vaags, JA Rosenfeld, JW Ahn, D Merico, ...Human molecular genetics 23 (10), 2752-2768, 2014201
160
2014
Comprehensive analysis of mammalian miRNA* species and their role in myeloid cells
F Kuchenbauer, SM Mah, M Heuser, A McPherson, J Rüschmann, ...Blood, The Journal of the American Society of Hematology 118 (12), 3350-3358, 2011201
124
2011
DYRK1A haploinsufficiency causes a new recognizable syndrome with microcephaly, intellectual disability, speech impairment, and distinct facies
J Ji, H Lee, B Argiropoulos, N Dorrani, J Mann, JA Martinez-Agosto, ...European Journal of Human Genetics 23 (11), 1473-1481, 2015201
109
2015
Cell of origin in AML: susceptibility to MN1-induced transformation is regulated by the MEIS1/AbdB-like HOX protein complex
M Heuser, H Yun, T Berg, E Yung, B Argiropoulos, F Kuchenbauer, ...Cancer cell 20 (1), 39-52, 2011201
107
2011
CHD2 haploinsufficiency is associated with developmental delay, intellectual disability, epilepsy and neurobehavioural problems
S Chénier, G Yoon, B Argiropoulos, J Lauzon, R Laframboise, JW Ahn, ...Journal of neurodevelopmental disorders 6, 1-9, 2014201
87
2014
Vitamin D–Binding Protein Deficiency and Homozygous Deletion of the GC Gene
CM Henderson, SL Fink, H Bassyouni, B Argiropoulos, L Brown, TJ Laha, ...New England Journal of Medicine 380 (12), 1150-1157, 2019201
51
2019
Linkage of the potent leukemogenic activity of Meis1 to cell-cycle entry and transcriptional regulation of cyclin D3
B Argiropoulos, E Yung, P Xiang, CY Lo, F Kuchenbauer, L Palmqvist, ...Blood, The Journal of the American Society of Hematology 115 (20), 4071-4082, 2010201
39
2010
MicroRNA-223 dose levels fine tune proliferation and differentiation in human cord blood progenitors and acute myeloid leukemia
B Gentner, N Pochert, A Rouhi, F Boccalatte, T Plati, T Berg, SM Sun, ...Experimental hematology 43 (10), 858-868. e7, 2015201
39
2015
Constitutive IRF8 expression inhibits AML by activation of repressed immune response signaling
A Sharma, H Yun, N Jyotsana, A Chaturvedi, A Schwarzer, E Yung, ...Leukemia 29 (1), 157-168, 2015201
38
2015
Optimized serial expansion of human induced pluripotent stem cells using low-density inoculation to generate clinically relevant quantities in vertical-wheel bioreactors
BS Borys, T So, J Colter, T Dang, EL Roberts, T Revay, L Larijani, ...Stem Cells Translational Medicine 9 (9), 10-1052, 2020202
36
2020
Overcoming bioprocess bottlenecks in the large-scale expansion of high-quality hiPSC aggregates in vertical-wheel stirred suspension bioreactors
BS Borys, T Dang, T So, L Rohani, T Revay, T Walsh, M Thompson, ...Stem Cell Research & Therapy 12 (1), 1-19, 2021202
35
2021
Identification of E74-like factor 1 (ELF1) as a transcriptional regulator of the Hox cofactor MEIS1
P Xiang, C Lo, B Argiropoulos, CB Lai, A Rouhi, S Imren, X Jiang, ...Experimental hematology 38 (9), 798-808. e2, 2010201
29
2010
Refinement of the critical region of 1q41q42 microdeletion syndrome identifies FBXO28 as a candidate causative gene for intellectual disability and seizures
PYB Au, B Argiropoulos, JS Parboosingh, A Micheil InnesAmerican Journal of Medical Genetics Part A 164 (2), 441-448, 2014201
27
2014
SS-31 peptide reverses the mitochondrial fragmentation present in fibroblasts from patients with DCMA, a mitochondrial cardiomyopathy
P Machiraju, X Wang, R Sabouny, J Huang, T Zhao, F Iqbal, M King, ...Frontiers in Cardiovascular Medicine 6, 167, 2019201
25
2019
19p13. 2 microduplication causes a Sotos syndrome‐like phenotype and alters gene expression
AM Lehman, C Du Souich, D Chai, P Eydoux, JL Huang, AK Fok, L Avila, ...Clinical genetics 81 (1), 56-63, 2012201
18
2012
Genotype–phenotype characterization in 13 individuals with chromosome Xp11. 22 duplications
SE Grams, B Argiropoulos, M Lines, P Chakraborty, J Mcgowan‐Jordan, ...American Journal of Medical Genetics Part A 170 (4), 967-977, 2016201
18
2016
Cell fate decisions in malignant hematopoiesis: leukemia phenotype is determined by distinct functional domains of the MN1 oncogene
CK Lai, Y Moon, F Kuchenbauer, DT Starzcynowski, B Argiropoulos, ...PloS one 9 (11), e112671, 2014201
17
2014
Delineating domains and functions of NUP98 contributing to the leukemogenic activity of NUP98-HOX fusions
E Yung, S Sekulovic, B Argiropoulos, CK Lai, M Leung, T Berg, S Vollett, ...Leukemia research 35 (4), 545-550, 2011201
17
2011
Prenatal array comparative genomic hybridization in fetuses with structural cardiac anomalies
J Lazier, D Fruitman, J Lauzon, F Bernier, B Argiropoulos, J Chernos, ...Journal of Obstetrics and Gynaecology Canada 38 (7), 619-626, 2016201
14
2016
Five patients with a chromosome 1q21. 1 triplication show macrocephaly, increased weight and facial similarities
A Van Dijck, IM van der Werf, E Reyniers, S Scheers, M Azage, K Siefkas, ...European journal of medical genetics 58 (10), 503-508, 2015201
14
2015